This paper is only available as a PDF. To read, Please Download here.
References
- Cardiac electrophysiologic effects of moricizine hydrochloride.Am J Cardiol. 1990; 65: 15D-20D
- Use dependent block of sodium currents by ethmozine in voltage clamped internally perfused canine cardiac Purkinje cells.J Mol Cell Cardiol. 1988; 20: 255-265
- Effects of ethmozine on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electro-physiologic matrix.J Pharmacol Exp Ther. 1989; 248: 1158-1166
- Action of ethmozine on normal and anomalous forms of Purkinje fiber automaticity in the dog.Kardiologia. 1986; 26: 10-15
- Antiarrhythmic effects of ethmozine in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.J Pharmacol Exp Ther. 1983; 227: 578-586
- Electrophysiology of ethmozine (moricizine HCL) for ventricular tachycardia.Am J Cardiol. 1987; 60: 67F-72F
- Dose efficacy of moricizine on suppression of ventricular arrhythmias.Am J Cardiol. 1990; 65: 26D-31D
- Clinical pharmacokinetics of moricizine.Am J Cardiol. 1990; 65: 21D-25D
- Cimetidine inhibition of ethmozine metabolism.Clin Pharmacol Ther. 1985; 37: 665-668
- Serum digoxin concentrations during ethmozine therapy.Am Heart J. 1986; 111: 667-672
- Effects of ethmozine (moricizine HCL) in ventricular function using echocardiographic, hemodynamic and radionuclide assessments.Am J Cardiol. 1987; 60: 73F-77F
- Ethmozine, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation. 1980; 61: 450-457
- Ethmozine suppression of single and repetitive ventricular premature depolarization during therapy: documentation of efficacy and long-term safety.Am Heart J. 1983; 106: 85-91
- Efficacy and tolerance of ethmozine (moricizine HCl) in placebo controlled trials.Am J Cardiol. 1987; 60: 48F-51F
- Effect of encainide, flecainide, inipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.Am J Cardiol. 1988; 61: 501-509
- Preliminary Report. Effects of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression of the myocardial infarction.N Engl J Med. 1989; 321: 406-411
- Comparison of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.Am J Cardiol. 1990; 65: 32D-40D
- Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.Am J Cardiol. 1987; 60: 59F-66F
- Efficacy of moricizine in malignant ventricular arrhythmias.Am J Cardiol. 1990; 65: 41D-46D
- Ethmozine (moricizine HCl): a promising drug for “automatic” atrial ectopic tachycardia.Am J Cardiol. 1987; 60: 83F-86F
- Ethmozine I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.Am Heart J. 1984; 108: 475-482
- Ethmozine II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.Am Heart J. 1984; 108: 483-489
- Noncardiac adverse effects and organ toxicity of moricizine during short and long term studies.Am J Cardiol. 1990; 60: 47D-50D
- Aggravation of arrhythmia by antiarrhythmic drugs. Incidence and predictors.Am J Cardiol. 1987; 59: 38E-44E
- Efficacy and safety of moricizine in congestive heart failure: experience in the United States.Am Heart J. 1989; 119: 1-7
- Congestive heart failure induced by six of the new antiarrhythmic drugs.J Am Coll Cardiol. 1989; 14: 1326-1330
Article info
Publication history
Accepted:
August 3,
1991
Received in revised form:
August 2,
1991
Received:
June 10,
1991
Identification
Copyright
© 1991 Published by Elsevier Inc.
